Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 3/20 | 0.64 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.59 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.59 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.59 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.57 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.57 |
| ▸ | GLP1R | P43220 | 6/20 | 0.57 |
| ▸ | GIPR | P48546 | 6/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29516785 | 1.00 | CALCR (0.64) | CALCRNTSR1CRHR1CRHR2OPRD1 | |
| SCHEMBL29533605 | 0.98 | CALCR (0.63) | CALCRNTSR1CRHR1CRHR2OPRD1 | |
| SCHEMBL11651841 | 0.96 | CALCR (0.65) | CALCRNTSR1CRHR1CRHR2OPRD1 | |
| SCHEMBL30439066 | 0.96 | CALCR (0.66) | CALCRCRHR1CRHR2OPRD1OPRM1 | |
| SCHEMBL11652679 | 0.95 | CALCR (0.65) | CALCRCRHR1CRHR2OPRD1OPRM1 | |
| SCHEMBL11651860 | 0.95 | CALCR (0.64) | CALCRNTSR1CRHR1CRHR2OPRD1 | |
| SCHEMBL11650961 | 0.95 | OPRD1 (0.60) | CALCROPRD1OPRM1OPRK1GLP1R | |
| SCHEMBL11667794 | 0.95 | CALCR (0.64) | CALCRCRHR1CRHR2OPRD1OPRM1 | |
| SCHEMBL11665206 | 0.94 | CALCR (0.62) | CALCRNTSR1CRHR1CRHR2OPRD1 | |
| SCHEMBL11662077 | 0.94 | CALCR (0.67) | CALCRCRHR1CRHR2OPRD1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | CALCR 118/4885NTSR1 18/4885CRHR1 195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.